Destiny Pharma PLC - ESG Rating & Company Profile powered by AI
If you are employed by Destiny Pharma PLC and you wish to licence your ESG rating, please get in touch. This ESG score for Destiny Pharma PLC indicates the company's transparency towards the United Nations Sustainable Development Goals. This assessment of Destiny Pharma PLC was assembled by All Street Sevva using leading artificial intelligence.
Destiny Pharma PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.2; made up of an environmental score of 2.7, social score of 4.8 and governance score of 8.0.
5.2
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
658 | Transchem Ltd | 5.3 | High |
658 | Zenith Healthcare Ltd | 5.3 | High |
687 | Destiny Pharma PLC | 5.2 | High |
687 | Cardiol Therapeutics Inc | 5.2 | High |
687 | Cell Source Inc | 5.2 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Destiny Pharma PLC have an accelerator or VC vehicle to help deliver innovation?
Does Destiny Pharma PLC disclose current and historical energy intensity?
Does Destiny Pharma PLC report the average age of the workforce?
Does Destiny Pharma PLC reference operational or capital allocation in relation to climate change?
Does Destiny Pharma PLC disclose its ethnicity pay gap?
Does Destiny Pharma PLC disclose cybersecurity risks?
Does Destiny Pharma PLC offer flexible work?
Does Destiny Pharma PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Destiny Pharma PLC disclose the number of employees in R&D functions?
Does Destiny Pharma PLC conduct supply chain audits?
Does Destiny Pharma PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Destiny Pharma PLC conduct 360 degree staff reviews?
Does Destiny Pharma PLC disclose the individual responsible for D&I?
Does Destiny Pharma PLC disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Destiny Pharma PLC disclose current and / or historical scope 2 emissions?
Does Destiny Pharma PLC disclose water use targets?
Does Destiny Pharma PLC have careers partnerships with academic institutions?
Did Destiny Pharma PLC have a product recall in the last two years?
Does Destiny Pharma PLC disclose incidents of discrimination?
Does Destiny Pharma PLC allow for Work Councils/Collective Agreements to be formed?
Has Destiny Pharma PLC issued a profit warning in the past 24 months?
Does Destiny Pharma PLC disclose parental leave metrics?
Does Destiny Pharma PLC disclose climate scenario or pathway analysis?
Does Destiny Pharma PLC disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Destiny Pharma PLC disclose the pay ratio of women to men?
Does Destiny Pharma PLC support suppliers with sustainability related research and development?
Does Destiny Pharma PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Destiny Pharma PLC reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Destiny Pharma PLC involved in embryonic stem cell research?
Does Destiny Pharma PLC disclose GHG and Air Emissions intensity?
Does Destiny Pharma PLC disclose its waste policy?
Does Destiny Pharma PLC report according to TCFD requirements?
Does Destiny Pharma PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Destiny Pharma PLC disclose energy use targets?
Does Destiny Pharma PLC disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Destiny Pharma PLC have a policy relating to cyber security?
Have a different question?
Potential Risks for Destiny Pharma PLC
These potential risks are based on the size, segment and geographies of the company.
Destiny Pharma plc, a biotechnology company, focuses on the discovery, development, and commercialization of medicines for the treatment of infectious diseases in the United Kingdom. The company is involved in developing NTCD-M3 that is in Phase III clinical trial for the prevention of recurrent Clostridioides diffcile infections; XF-73 Nasal, which is in Phase II clinical trial for the prevention of post-surgical staphylococcal infection; and XF-73 Dermal that is in Phase I clinical trial for the treatment of skin infections of antibiotic resistant bacteria. It also develops SPOR-COV, biotherapeutic product, which is in preclinical stage for the prevention of COVID-19 and other viral respiratory infections; and XF Drugs Biofilm that is in preclinical stage for the treatment of antibiotic resistant biofilm and bacterial aggregate associated infections. In addition, the company is involved in the development of XF drugs for the treatment of respiratory, oral mucosa, and ocular infection diseases. Destiny Pharma plc has collaboration agreements with China Medical System Holdings Limited; SporeGen Limited; the University of Southampton; Aston University; the University of Sheffield; and Cardiff University and Tianjin Medical University. The company was incorporated in 1996 and is based in Brighton, the United Kingdom.